Zobrazeno 1 - 10
of 26
pro vyhledávání: '"G H, Jackson"'
Autor:
H. V. Giles, M. T. Drayson, B. Kishore, C. Pawlyn, M. Kaiser, G. Cook, R. de Tute, R. G. Owen, D. Cairns, T. Menzies, F. E. Davies, G. J. Morgan, G. Pratt, G. H. Jackson
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Deeper responses are associated with improved survival in patients being treated for myeloma. However, the sensitivity of the current blood-based assays is limited. Historical studies suggested that normalisation of the serum free light chai
Externí odkaz:
https://doaj.org/article/0e9a723e00fb40978aa075c750847b8d
Autor:
J M Allan, N J Sunter, J R Bailey, A R Pettitt, R J Harris, C Pepper, C Fegan, A G Hall, L Deignan, C M Bacon, J C Pointon, R S Houlston, P Broderick, T Mainou-Fowler, G H Jackson, G Summerfield, P A Evans, J C Strefford, A Parker, D Oscier, G Pratt, D J Allsup
Publikováno v:
Leukemia. 24:877-881
A low penetrance risk allele (defined by rs872071) for chronic lymphocytic leukaemia (CLL) has been identified at the interferon regulatory factor 4 (IRF4)|[sol]|multiple myeloma oncogene (MUM1) locus at 6p25.3.1 Given a putative role for IRF4 in the
Autor:
D Miekeljohn, J Davison, Goodlad, Jennifer Wilkinson, Pamela McKay, Dominic Culligan, J Lewis, Robin J Prescott, J. White, H Lucraft, G H Jackson, S. J. Proctor, Tryfonia Mainou-Fowler, Michal Sieniawski, Anne Lennard
Publikováno v:
Annals of Oncology. 19:iv216-iv222
Autor:
Tyson B. Rogers, Jonathan I. Ravdin, Mohamed D. Abd-Alla, Selvan Reddy, Terry F. G. H. Jackson
Publikováno v:
Infection and Immunity. 74:3897-3903
We monitored 93 subjects cured of amebic liver abscess (ALA) and 963 close associate controls in Durban, South Africa, and determined by enzyme-linked immunosorbent assay that the intestinal immunoglobulin A (IgA) antibody response to the Entamoeba h
Autor:
P. R. A. Taylor, J. M. White, R. J. Prescott, B. Angus, M. J. Galloway, G. H. Jackson, A. M. Lessells, H. H. Lucraft, G. P. Summerfield, S. J. Proctor, null On Behalf Of The Scotland and Newca
Publikováno v:
Leukemia & Lymphoma. 47:2321-2330
Two hundred untreated patients with low grade NHL (KIEL), including 155 follicular NHL, were randomized to six courses of treatment with chlorambucil 20 mg m-2 for 3 days and dexamethasone 4 mg bd for 5 days (CD) vs the same regimen plus oral idarubi
Autor:
Jonathan I. Ravdin, Ginny C. Soong, Mohamed D. Abd Alla, Mary B. Mazanec, Terry F. G. H. Jackson
Publikováno v:
Infection and Immunity. 72:3974-3980
Immunity toEntamoebaspecies intestinal infection is associated with the presence of intestinal IgA antibodies against the parasite's galactose-inhibitable adherence lectin. We determined the epitope specificity of serum and intestinal antilectin IgA
Autor:
William A. Petri, Aleida Eubanks, David M. Lyerly, Lauren A. Lockhart, James M. Dodson, Jason Napodano, Paul W. Lenkowski, Terry F. G. H. Jackson, Barbara J. Mann
Publikováno v:
The Journal of Infectious Diseases. 179:460-466
Entamoeba histolytica causes invasive amebiasis, a major parasitic disease of the developing world, whose primary symptoms are liver abscess and colitis. All strains of E. histolytica express a 260-kDa surface Gal/GalNAc lectin that is antigenically
Autor:
J T, GRESH, G H, JACKSON
Publikováno v:
Industrial medicinesurgery. 15
Publikováno v:
International journal of laboratory hematology. 30(1)
Bortezomib (Velcade) is a boron containing molecule which reversibly inhibits the proteasome, an intracellular organelle which is central to the breakdown of ubiquinated proteins and consequently crucial for normal cellular homeostasis. Phase II clin
Autor:
S J, Proctor, P R, Taylor, B, Angus, K, Wood, A L, Lennard, H, Lucraft, P J, Carey, A, Stark, A, Iqbal, A, Haynes, N, Russel, R C, Leonard, D, Culligan, J, Conn, G H, Jackson
Publikováno v:
European journal of haematology. Supplementum. 64
One hundred and seven patients (61 with diffuse large B-cell non-Hodgkin's lymphomas and 46 with Hodgkin's disease) in relapse or following of primary therapy received ifosfamide 3 g/m2 i.v. daily for 3 days in combination with epirubicin 50 mg/m2 i.